我们能通过专门的乳腺癌护理来抵消受限于创新的机会吗? 在REAL-NOTE研究中,
Leonor Vasconcelos de Matos1, Marcio Debiasi1, Teresa Gantes Padrão1
1Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal.
Breast (Edinburgh, Scotland)
|September 4, 2024
概括
在经过认证的乳腺单位提供高质量的护理,可以提供与早期三阴性乳腺癌 (TNBC) 免疫疗法相当的结果. 这项实践研究表明,专门的多学科团队可以达到与创新疗法相似的结果.
科学领域:
- 在瘤学瘤学.
- 乳腺癌研究研究 乳腺癌研究
- 临床试验 临床试验
背景情况:
- 在KEYNOTE-522试验中,Pembrolizumab和早期三阴性乳腺癌 (TNBC) 的化疗改善了病理完整反应 (pCR) 和无事件生存 (EFS).
- 分析了经过认证的乳腺单位的现实数据,以比较单独使用标准化疗的结果与KN-522试验的结果.
研究的目的:
- 评估是否在经过认证的乳腺病房中提供高质量的护理可以达到与KEYNOTE-522试验中添加布罗利祖马布治疗早期TNBC的结果相似的结果.
- 评估专业多学科护理对现实世界TNBC队列治疗结果的影响.
主要方法:
- 一项观察性,回顾性,单中心的队列研究利用了来自机构数据库的真实世界数据.
- 纳入标准反映了KN-522试验:以前未经治疗的II或III期TNBC患者在2012年至2022年期间被诊断出接受新辅助化疗.
- 主要终点是pCR和EFS;整体存活率 (OS) 是次要终点.
主要成果:
- 总共包括168名患者 (平均年龄55岁).
- 病理完整反应 (pCR) 在52.7%的病例中实现.
- 在36个月后,无事件生存率 (EFS) 为83.3%,总生存率 (OS) 为89%.
结论:
- 在这种仅用化疗治疗的真实世界队列中,结果与KN-522试验的实验分支数量相似.
- 这些发现表明,在经过认证的单位中由专业的多学科团队提供的护理可能与结合新型免疫疗法一样具有影响力.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Nursing Ethical Principles II
935
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
935
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


